Skip to main content

. 1973 May;177(5):632–642.

Poorly differentiated neoplasms of the thyroid gland.

C G Thomas Jr, J A Buckwalter

PMCID: PMC1355613 PMID: 4122232

632

Images in this article

Fig. 2.
on p.634

Fig. 3.
on p.634

Fig. 4.
on p.635

Fig. 5.
on p.635

Fig. 13.
on p.640

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BERENBLUM I. A speculative review; the probable nature of promoting action and its significance in the understanding of the mechanism of carcinogenesis. Cancer Res. 1954 Aug;14(7):471–477. [PubMed] [Google Scholar]
BERKSON J., GAGE R. P. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin. 1950 May 24;25(11):270–286. [PubMed] [Google Scholar]
BUCKWALTER J. A., MASON E. E., ROWLEY R. D., BROER R. A. Thyroid cancer biology. AMA Arch Surg. 1958 May;76(5):667–676. doi: 10.1001/archsurg.1958.01280230007002. [DOI] [PubMed] [Google Scholar]
Beemer R. K., Baker H. W. Anaplastic cancer of the thyroid. Northwest Med. 1970 Jun;69(6):417–420. [PubMed] [Google Scholar]
Buckwalter J. A., Thomas C. G., Jr Selection of surgical treatment for well differentiated thyroid carcinomas. Ann Surg. 1972 Oct;176(4):565–578. doi: 10.1097/00000658-197210000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
CRILE G., Jr The endocrine dependency of certain thyroid cancers and the danger that hypothyroidism may stimulate their growth. Cancer. 1957 Nov-Dec;10(6):1119–1137. doi: 10.1002/1097-0142(195711/12)10:6<1119::aid-cncr2820100607>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
CUTLER S. J., EDERER F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958 Dec;8(6):699–712. doi: 10.1016/0021-9681(58)90126-7. [DOI] [PubMed] [Google Scholar]
GRANNER D. K., BUCKWALTER J. A. Poorly differentiated carcinoma of the thyroid gland. Surg Gynecol Obstet. 1963 Jun;116:650–656. [PubMed] [Google Scholar]
Gottlieb J. A., Hill C. S., Jr, Ibanez M. L., Clark R. L. Chemotherapy of thyroid cancer. An evaluation of experience with 37 patients. Cancer. 1972 Sep;30(3):848–853. doi: 10.1002/1097-0142(197209)30:3<848::aid-cncr2820300336>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
Ibanez M. L., Russell W. O., Albores-Saavedra J., Lampertico P., White E. C., Clark R. L. Thyroid carcinoma--biologic behavior and mortality. Postmortem findings in 42 cases, including 27 in which the disease was fatal. Cancer. 1966 Aug;19(8):1039–1052. doi: 10.1002/1097-0142(196608)19:8<1039::aid-cncr2820190802>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
Israel L., Depierre A., Chahinian P. Combination chemotherapy for 418 cases of advanced cancer. Cancer. 1971 May;27(5):1089–1093. doi: 10.1002/1097-0142(197105)27:5<1089::aid-cncr2820270513>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
Rayfield E. J., Nishiyama R. H., Sisson J. C. Small cell tumors of the thyroid. A clinicopathologic study. Cancer. 1971 Oct;28(4):1023–1030. doi: 10.1002/1097-0142(1971)28:4<1023::aid-cncr2820280428>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
Silverberg S. G., Hutter R. V., Foote F. W., Jr Fatal carcinoma of the thyroid: histology, metastases, and causes of death. Cancer. 1970 Apr;25(4):792–802. doi: 10.1002/1097-0142(197004)25:4<792::aid-cncr2820250408>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
Thomas C. G., Jr, Pepper F. D., Owen J. Differentiation of malignant from benign lesions of the thyroid gland using complementary scanning with 75Selenomethionine and radioiodide. Ann Surg. 1969 Sep;170(3):396–408. doi: 10.1097/00000658-196909010-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

PDF (4.1 MB)

RESOURCES